All Purdue Pharma articles

  • Pharmaceuticals
    Article

    Compliance ramifications of proposed $26B opioid deal for pharma industry

    2021-07-29T17:27:00Z

    Three major drug distributors and drugmaker Johnson Johnson reached a proposed $26 billion multistate agreement for their alleged roles in fueling the nationwide opioid epidemic. The settlement imparts compliance lessons on the pharmaceutical industry at large.

  • McKinsey
    Article

    McKinsey to pay $573M for role in opioid epidemic

    2021-02-04T18:34:00Z

    McKinsey Company reached a $573 million settlement with 49 state attorneys general and the District of Columbia related to consulting services it provided to pharmaceutical companies that directly contributed to the opioid epidemic.

  • Health records
    Article

    Practice Fusion to overhaul compliance after $145M kickback resolution

    2020-02-05T16:37:00Z

    Practice Fusion will pay a total of $145 million to resolve criminal and civil investigations for its leading role in an opioid kickback scheme. Particularly notable are the new compliance obligations imposed upon it, which are as weighty and significant as the fine itself.

  • prescriptionpillbottle
    Blog post

    Opioid crisis sparks leadership changes at Purdue Pharma

    2018-08-21T10:45:00Z

    In an attempt to distance itself from the opioid epedemic, Purdue Pharma recently made some leadership changes to its board of directors and executive committee, as it battles hundreds of lawsuits across the United States concerning opioid-related deceptive sales and marketing practices that are the focus of U.S. enforcement authorities. ...